Skip to content
10-Q

Quarterly Report

PERFORMANT HEALTHCARE, INC.

0001550695-24-000098

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 6, 2024 78.29M sh
Shares Diluted Q3 2024 · Sep 30, 2024 77.75M sh
Shares Diluted Q3 2024 · Sep 30, 2024 77.23M sh
Shares Diluted Q3 2024 · Sep 30, 2023 76.45M sh
Shares Diluted Q3 2024 · Sep 30, 2023 75.91M sh
Capex Q3 2024 · Sep 30, 2024 $5.74M
Capex Q3 2024 · Sep 30, 2023 $2.96M
Operating Cash Flow Q3 2024 · Sep 30, 2024 $3.4M
Operating Cash Flow Q3 2024 · Sep 30, 2023 $5.75M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $7.78M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $7.25M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $17.31M
Stockholders Equity Q3 2024 · Sep 30, 2024 $75.24M
Stockholders Equity Q3 2024 · Dec 31, 2023 $80.71M
Current Liabilities Q3 2024 · Sep 30, 2024 $14.37M
Current Liabilities Q3 2024 · Dec 31, 2023 $12.38M
Total Liabilities Q3 2024 · Sep 30, 2024 $26.61M
Total Liabilities Q3 2024 · Dec 31, 2023 $18.32M
Current Assets Q3 2024 · Sep 30, 2024 $38.33M
Current Assets Q3 2024 · Dec 31, 2023 $39.78M
Total Assets Q3 2024 · Sep 30, 2024 $101.84M
Total Assets Q3 2024 · Dec 31, 2023 $99.03M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.03
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.12
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.12
Eps Basic Q3 2024 · Sep 30, 2024 −$0.03
Eps Basic Q3 2024 · Sep 30, 2024 −$0.12
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 −$0.12
Net Income Q3 2024 · Sep 30, 2024 −$2.38M
Net Income Q3 2024 · Sep 30, 2024 −$9.4M
Net Income Q3 2024 · Sep 30, 2023 −$580K
Net Income Q3 2024 · Sep 30, 2023 −$8.77M
Operating Income Q3 2024 · Sep 30, 2024 −$2.15M
Operating Income Q3 2024 · Sep 30, 2024 −$8.81M
Operating Income Q3 2024 · Sep 30, 2023 −$650K
Operating Income Q3 2024 · Sep 30, 2023 −$8.04M
Revenue Q3 2024 · Sep 30, 2024 $31.52M
Revenue Q3 2024 · Sep 30, 2024 $88.22M
Revenue Q3 2024 · Sep 30, 2023 $29.96M
Revenue Q3 2024 · Sep 30, 2023 $81.18M